Salwa Sami Ghoneim, an Egyptian Pharmacist has discovered a hybrid drug for the treatment of breast cancer by combining two types of drugs. The laboratory experiments proved the effectiveness of this hybrid drug as a stabilizer for enzymes, which increase the occurrence of tumors because helps to limit its activity that affects Cancer cell fission.
The discussion by video conference
A study prepared by Ghoneim, showed that treatment with this substance is less toxic than traditional chemotherapy since it specifically targets cancer cells and prevents its multiplication.
It was considered the first scientific research to be discussed by video conference. The researcher communicated with Dr. Darius Zlotos, a Pharmacy Professor and the Supervisor of the research in Germany.
The discussion committee
The discussion committee included: Dr. Khaled Abu Zaid the Pharmacy Faculty Dean at Sadat University, Ashraf Abadi the Pharmaceutical Chemistry Department Head, at German University, Darius Zlotos the Pharmacy Professor at German University, and Dr. Mohamed Zakaria Gad, the Graduate Studies Faculty Vice-Dean at the university.